Cencora, Inc. (COR) PB Ratio: 16.20
Is Cencora, Inc.’s P/B ratio high or low?
Cencora, Inc.'s P/B ratio of 16.20 is 86% below its 5-year average of 115.04, near the low end of its 5-year range (14.53–692.30).
55.68% below its 12-month average of 36.55.
COR PB Ratio Chart
COR Average PB Ratio Chart
COR Current vs Average PB Ratio Chart
COR PB Ratio Metrics
PB RATIO
16.20
PB RATIO AVG TTM
36.55
PB RATIO AVG 3Y
68.38
PB RATIO AVG 5Y
115.04
PB RATIO AVG 10Y
60.91
PB RATIO AVG 15Y
42.20
PB RATIO AVG 20Y
31.68
CURRENT VS TTM AVG
-55.68%
CURRENT VS 3Y AVG
-76.31%
CURRENT VS 5Y AVG
-85.92%
CURRENT VS 10Y AVG
-73.40%
CURRENT VS 15Y AVG
-61.61%
CURRENT VS 20Y AVG
-48.87%
COR Competitors' PB Ratio
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cencora, Inc. (COR) | $54.80B | 16.20 | 36.55 | 68.38 | 115.04 |
| Becton, Dickinson and Company (BDX) | $52.98B | 1.70 | 1.72 | 1.97 | 2.09 |
| Regeneron Pharmaceuticals, Inc. (REGN) | $63.06B | 2.10 | 2.35 | 3.21 | 3.54 |
| Humana Inc. (HUM) | $45.53B | 2.46 | 1.64 | 2.30 | 2.91 |
| IDEXX Laboratories, Inc. (IDXX) | $44.24B | 29.08 | 32.94 | 30.71 | 45.14 |
| Agilent Technologies, Inc. (A) | $36.67B | 5.18 | 5.56 | 6.11 | 6.98 |
| Zoetis Inc. (ZTS) | $33.36B | 10.40 | 12.94 | 15.21 | 16.72 |
| Centene Corporation (CNC) | $32.19B | 1.51 | 0.87 | 1.21 | 1.41 |
| Medline Inc. (MDLN) | $30.96B | 2.68 | 3.18 | 3.18 | 3.18 |
| Cigna Corporation (CI) | $78.83B | 1.87 | 1.87 | 2.03 | 1.94 |
P/B vs. its own history
At 16.20, P/B is richer than usual, sitting higher than 76% of its 20-year history.
20-year low
1.61
median
6.31
20-year high
692.30
Book Value Analysis
P/B Ratio
16.20
Market Price / Book Value per Share
Cencora, Inc. PB Ratio Formula & Definition
PB Ratio = Market Cap / Total Shareholders' Equity
The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cencora, Inc. PB Ratio FAQ
- What is the P/B ratio for Cencora, Inc. (COR)?
- The P/B ratio for COR stock is 16.20.
- Is Cencora, Inc.'s P/B ratio high or low?
- Cencora, Inc.'s P/B ratio of 16.20 is 86% below its 5-year average of 115.04, near the low end of its 5-year range (14.53–692.30).
- What is the TTM average P/B ratio for Cencora, Inc. (COR)?
- The TTM average P/B ratio for COR stock is 36.55.
- What is the 3Y average P/B ratio for Cencora, Inc. (COR)?
- The 3Y average P/B ratio for COR stock is 68.38.
- What is the 5Y average P/B ratio for Cencora, Inc. (COR)?
- The 5Y average P/B ratio for COR stock is 115.04.
- What is the 10Y average P/B ratio for Cencora, Inc. (COR)?
- The 10Y average P/B ratio for COR stock is 60.91.
- What is the 15Y average P/B ratio for Cencora, Inc. (COR)?
- The 15Y average P/B ratio for COR stock is 42.20.
- What is the 20Y average P/B ratio for Cencora, Inc. (COR)?
- The 20Y average P/B ratio for COR stock is 31.68.
Cencora, Inc. PB Ratio History
| DATE | PB RATIO |
|---|---|
| 2026-06-12 | 16.20 |
| 2026-06-11 | 16.19 |
| 2026-06-10 | 16.17 |
| 2026-06-09 | 16.08 |
| 2026-06-08 | 15.76 |
| 2026-06-05 | 15.82 |
| 2026-06-04 | 15.55 |
| 2026-06-03 | 15.16 |
| 2026-06-02 | 15.23 |
| 2026-06-01 | 15.22 |
| 2026-05-29 | 15.49 |
| 2026-05-28 | 15.40 |
| 2026-05-27 | 15.35 |
| 2026-05-26 | 15.57 |
| 2026-05-22 | 15.81 |
| 2026-05-21 | 15.26 |
| 2026-05-20 | 15.22 |
| 2026-05-19 | 15.31 |
| 2026-05-18 | 15.06 |
| 2026-05-15 | 14.82 |
| 2026-05-14 | 15.02 |
| 2026-05-13 | 14.70 |
| 2026-05-12 | 15.01 |
| 2026-05-11 | 14.93 |
| 2026-05-08 | 15.01 |
| 2026-05-07 | 14.70 |
| 2026-05-06 | 14.53 |
| 2026-05-05 | 31.31 |
| 2026-05-04 | 31.08 |
| 2026-05-01 | 31.11 |
| 2026-04-30 | 31.53 |
| 2026-04-29 | 31.88 |
| 2026-04-28 | 31.93 |
| 2026-04-27 | 31.75 |
| 2026-04-24 | 31.54 |
| 2026-04-23 | 31.87 |
| 2026-04-22 | 31.55 |
| 2026-04-21 | 31.97 |
| 2026-04-20 | 33.06 |
| 2026-04-17 | 33.53 |
| 2026-04-16 | 32.99 |
| 2026-04-15 | 32.50 |
| 2026-04-14 | 32.74 |
| 2026-04-13 | 32.66 |
| 2026-04-10 | 32.84 |
| 2026-04-09 | 33.00 |
| 2026-04-08 | 33.26 |
| 2026-04-07 | 32.84 |
| 2026-04-06 | 32.85 |
| 2026-04-02 | 33.24 |
| 2026-04-01 | 32.51 |
| 2026-03-31 | 32.15 |
| 2026-03-30 | 31.72 |
| 2026-03-27 | 31.98 |
| 2026-03-26 | 32.55 |
| 2026-03-25 | 33.27 |
| 2026-03-24 | 33.50 |
| 2026-03-23 | 32.81 |
| 2026-03-20 | 33.46 |
| 2026-03-19 | 33.95 |
| 2026-03-18 | 33.28 |
| 2026-03-17 | 34.26 |
| 2026-03-16 | 35.40 |
| 2026-03-13 | 35.82 |
| 2026-03-12 | 36.09 |
| 2026-03-11 | 35.85 |
| 2026-03-10 | 36.05 |
| 2026-03-09 | 37.03 |
| 2026-03-06 | 36.69 |
| 2026-03-05 | 36.77 |
| 2026-03-04 | 37.68 |
| 2026-03-03 | 38.02 |
| 2026-03-02 | 38.14 |
| 2026-02-27 | 38.09 |
| 2026-02-26 | 37.53 |
| 2026-02-25 | 37.16 |
| 2026-02-24 | 37.29 |
| 2026-02-23 | 37.46 |
| 2026-02-20 | 36.96 |
| 2026-02-19 | 36.76 |
| 2026-02-18 | 36.87 |
| 2026-02-17 | 36.84 |
| 2026-02-13 | 36.93 |
| 2026-02-12 | 35.93 |
| 2026-02-11 | 37.43 |
| 2026-02-10 | 36.85 |
| 2026-02-09 | 37.18 |
| 2026-02-06 | 36.77 |
| 2026-02-05 | 36.04 |
| 2026-02-04 | 33.77 |
| 2026-02-03 | 46.51 |
| 2026-02-02 | 46.75 |
| 2026-01-30 | 46.19 |
| 2026-01-29 | 45.27 |
| 2026-01-28 | 45.07 |
| 2026-01-27 | 45.79 |
| 2026-01-26 | 45.71 |
| 2026-01-23 | 45.45 |
| 2026-01-22 | 45.32 |
| 2026-01-21 | 45.23 |
| 2026-01-20 | 45.09 |
| 2026-01-16 | 45.63 |
| 2026-01-15 | 45.69 |
| 2026-01-14 | 44.99 |
| 2026-01-13 | 44.47 |
| 2026-01-12 | 43.99 |
| 2026-01-09 | 43.16 |
| 2026-01-08 | 43.17 |
| 2026-01-07 | 43.77 |
| 2026-01-06 | 44.51 |
| 2026-01-05 | 43.84 |
| 2026-01-02 | 43.57 |
| 2025-12-31 | 43.43 |
| 2025-12-30 | 43.73 |
| 2025-12-29 | 43.74 |
| 2025-12-26 | 43.85 |
| 2025-12-24 | 43.71 |
| 2025-12-23 | 43.79 |
| 2025-12-22 | 43.72 |
| 2025-12-19 | 43.84 |
| 2025-12-18 | 43.79 |
| 2025-12-17 | 44.10 |
| 2025-12-16 | 43.94 |
| 2025-12-15 | 45.04 |
| 2025-12-12 | 44.49 |
| 2025-12-11 | 44.30 |
| 2025-12-10 | 43.82 |
| 2025-12-09 | 43.37 |
| 2025-12-08 | 43.44 |
| 2025-12-05 | 43.67 |
| 2025-12-04 | 43.41 |
| 2025-12-03 | 43.11 |
| 2025-12-02 | 45.09 |
| 2025-12-01 | 46.30 |
| 2025-11-28 | 47.44 |
| 2025-11-26 | 47.39 |
| 2025-11-25 | 48.18 |
| 2025-11-24 | 36.70 |
| 2025-11-21 | 36.05 |
| 2025-11-20 | 35.70 |
| 2025-11-19 | 35.56 |
| 2025-11-18 | 35.65 |
| 2025-11-17 | 35.99 |
| 2025-11-14 | 35.68 |
| 2025-11-13 | 36.03 |
| 2025-11-12 | 35.83 |
| 2025-11-11 | 35.99 |
| 2025-11-10 | 35.95 |
| 2025-11-07 | 35.56 |
| 2025-11-06 | 35.52 |
| 2025-11-05 | 34.90 |
| 2025-11-04 | 33.97 |
| 2025-11-03 | 33.61 |
| 2025-10-31 | 33.31 |
| 2025-10-30 | 33.64 |
| 2025-10-29 | 32.85 |
| 2025-10-28 | 33.09 |
| 2025-10-27 | 33.13 |
| 2025-10-24 | 32.80 |
| 2025-10-23 | 32.39 |
| 2025-10-22 | 32.61 |
| 2025-10-21 | 32.42 |
| 2025-10-20 | 32.28 |
| 2025-10-17 | 32.01 |
| 2025-10-16 | 31.49 |
| 2025-10-15 | 31.51 |
| 2025-10-14 | 31.35 |
| 2025-10-13 | 31.25 |
| 2025-10-10 | 31.35 |
| 2025-10-09 | 30.97 |
| 2025-10-08 | 30.62 |
| 2025-10-07 | 30.44 |
| 2025-10-06 | 30.10 |
| 2025-10-03 | 29.85 |
| 2025-10-02 | 30.42 |
| 2025-10-01 | 30.74 |
| 2025-09-30 | 30.81 |
| 2025-09-29 | 30.37 |
| 2025-09-26 | 30.27 |
| 2025-09-25 | 29.46 |
| 2025-09-24 | 30.40 |
| 2025-09-23 | 29.81 |
| 2025-09-22 | 28.47 |
| 2025-09-19 | 28.59 |
| 2025-09-18 | 28.67 |
| 2025-09-17 | 28.50 |
| 2025-09-16 | 28.59 |
| 2025-09-15 | 28.73 |
| 2025-09-12 | 29.83 |
| 2025-09-11 | 29.85 |
| 2025-09-10 | 29.21 |
| 2025-09-09 | 29.45 |
| 2025-09-08 | 29.37 |
| 2025-09-05 | 28.84 |
| 2025-09-04 | 28.86 |
| 2025-09-03 | 29.10 |
| 2025-09-02 | 29.07 |
| 2025-08-29 | 28.75 |
| 2025-08-28 | 28.58 |
| 2025-08-27 | 28.65 |
| 2025-08-26 | 28.56 |
| 2025-08-25 | 28.42 |
| 2025-08-22 | 28.85 |
| 2025-08-21 | 29.90 |
| 2025-08-20 | 29.94 |
| 2025-08-19 | 29.06 |
| 2025-08-18 | 28.63 |
| 2025-08-15 | 28.87 |
| 2025-08-14 | 29.07 |
| 2025-08-13 | 28.69 |
| 2025-08-12 | 28.51 |
| 2025-08-11 | 28.66 |
| 2025-08-08 | 28.11 |
| 2025-08-07 | 27.45 |
| 2025-08-06 | 27.98 |
| 2025-08-05 | 56.31 |
| 2025-08-04 | 56.56 |
| 2025-08-01 | 55.54 |
| 2025-07-31 | 55.11 |
| 2025-07-30 | 56.21 |
| 2025-07-29 | 55.82 |
| 2025-07-28 | 55.13 |
| 2025-07-25 | 55.93 |
| 2025-07-24 | 55.95 |
| 2025-07-23 | 56.52 |
| 2025-07-22 | 56.43 |
| 2025-07-21 | 56.37 |
| 2025-07-18 | 56.41 |
| 2025-07-17 | 56.70 |
| 2025-07-16 | 57.37 |
| 2025-07-15 | 56.76 |
| 2025-07-14 | 57.22 |
| 2025-07-11 | 56.86 |
| 2025-07-10 | 57.27 |
| 2025-07-09 | 57.82 |
| 2025-07-08 | 57.41 |
| 2025-07-07 | 58.27 |
| 2025-07-03 | 57.06 |
| 2025-07-02 | 56.09 |
| 2025-07-01 | 56.89 |
| 2025-06-30 | 57.76 |
| 2025-06-27 | 57.67 |
| 2025-06-26 | 57.13 |
| 2025-06-25 | 56.31 |
| 2025-06-24 | 56.65 |
| 2025-06-23 | 56.46 |
| 2025-06-20 | 56.57 |
| 2025-06-18 | 57.16 |
| 2025-06-17 | 56.48 |
| 2025-06-16 | 56.34 |
| 2025-06-13 | 56.93 |
| 2025-06-12 | 56.83 |
| 2025-06-11 | 55.21 |
| 2025-06-10 | 54.75 |
| 2025-06-09 | 54.69 |
| 2025-06-06 | 55.66 |
| 2025-06-05 | 55.55 |
| 2025-06-04 | 55.67 |
| 2025-06-03 | 56.16 |
| 2025-06-02 | 56.26 |
Showing the most recent 260 of 4,751 data points. The chart above shows the full history.
Related Metrics
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Robert Mauch